Purple Biotech (PPBT) Shares Outstanding (2014 - 2026)

Purple Biotech (PPBT) Shares Outstanding (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 6,012.74 Bn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 47.82 Bn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.44 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 400.00 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 62.06 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 198.10 Mn
10 Purple Biotech 1.31 Bn 1.31 Bn - 960.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 960.11 Mn
Dec 31, 2025 960.11 Mn
Sep 30, 2025 163,957.00
Jun 30, 2025 163,957.00
Mar 31, 2025 163,957.00
Dec 31, 2024 163,957.00
Sep 30, 2024 110,666.00
Jun 30, 2024 110,666.00
Mar 31, 2024 110,666.00
Dec 31, 2023 110,666.00
Sep 30, 2023 90,405.00
Jun 30, 2023 90,405.00
Mar 31, 2023 90,405.00
Dec 31, 2022 90,405.00
Sep 30, 2022 87,840.00
Jun 30, 2022 87,840.00
Mar 31, 2022 87,840.00
Dec 31, 2021 87,840.00
Sep 30, 2021 87.56 Mn
Jun 30, 2021 87.27 Mn